Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenfeng Duan

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Biomed Research International|June 21, 2014
Role of microRNA-1 in human cancer and its therapeutic potentialsChao Han, Zujiang Yu, Zhenfeng Duan, et al.
Biochemical Pharmacology|June 7, 2024
Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcomaRobert L Walker, Francis J Hornicek, Zhenfeng Duan
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
cDNA Technologies and their application to drug resistance research: power, potential and problemsZhenfeng Duan, Diana E. Lamendola, Michael V. Seiden
Molecular Cancer Therapeutics|July 15, 2004
Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cellsZhenfeng Duan, Katherine A Brakora, Michael V Seiden
Cancers|August 28, 2025
Advances in the Molecular Biology of Chondrosarcoma for Drug Discovery and Precision MedicineRobert Lee Walker, Francis J Hornicek, Zhenfeng Duan
Analytical Cellular Pathology (Amsterdam)|February 25, 2020
Diagnosis, Therapy, and Prognosis for Hepatocellular CarcinomaZhigang Ren, Xiaochao Ma, Zhenfeng Duan, et al.
Current Cancer Drug Targets|August 19, 2017
An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-GlycoproteinXiaoqian Yang, Xiaoduan Li, Zhenfeng Duan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 23, 2019
Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathwayShen Shen, Dylan C Dean, Zujiang Yu, et al.
Cancer Metastasis Reviews|June 26, 2016
The roles and implications of exosomes in sarcomaLi Min, Jacson Shen, Chongqi Tu, et al.
Oncotarget|November 16, 2017
Novel strategies to prevent the development of multidrug resistance (MDR) in cancerJinglu Wang, Nicole Seebacher, Huirong Shi, et al.
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Biomed Research International|June 21, 2014
Role of microRNA-1 in human cancer and its therapeutic potentialsChao Han, Zujiang Yu, Zhenfeng Duan, et al.
Biochemical Pharmacology|June 7, 2024
Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcomaRobert L Walker, Francis J Hornicek, Zhenfeng Duan
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
cDNA Technologies and their application to drug resistance research: power, potential and problemsZhenfeng Duan, Diana E. Lamendola, Michael V. Seiden
Molecular Cancer Therapeutics|July 15, 2004
Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cellsZhenfeng Duan, Katherine A Brakora, Michael V Seiden
Cancers|August 28, 2025
Advances in the Molecular Biology of Chondrosarcoma for Drug Discovery and Precision MedicineRobert Lee Walker, Francis J Hornicek, Zhenfeng Duan
Analytical Cellular Pathology (Amsterdam)|February 25, 2020
Diagnosis, Therapy, and Prognosis for Hepatocellular CarcinomaZhigang Ren, Xiaochao Ma, Zhenfeng Duan, et al.
Current Cancer Drug Targets|August 19, 2017
An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-GlycoproteinXiaoqian Yang, Xiaoduan Li, Zhenfeng Duan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 23, 2019
Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathwayShen Shen, Dylan C Dean, Zujiang Yu, et al.
Cancer Metastasis Reviews|June 26, 2016
The roles and implications of exosomes in sarcomaLi Min, Jacson Shen, Chongqi Tu, et al.
Oncotarget|November 16, 2017
Novel strategies to prevent the development of multidrug resistance (MDR) in cancerJinglu Wang, Nicole Seebacher, Huirong Shi, et al.
Pageof 23